Methylphenidate for ADHD symptoms in KBG syndrome
Part of Genetic & congenital, Mental health clinical trials.
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 20 years old.
- You have a confirmed diagnosis of KBG syndrome (a change in the ANKRD11 gene or a related deletion).
- You have attention problems, ADHD-like symptoms, or a formal ADHD diagnosis that affects your daily life.
- You do not have any serious heart problems, uncontrolled epilepsy, or a history of psychosis or drug abuse.
- You have a caregiver or supervisor who can help with the study reports.
- You can understand and speak Dutch.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging (MRI) to see how methylphenidate affects brain activity in people with ADHD. It may help doctors better understand how this medicine works and who benefits most.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
This study uses brain scans (EEG) to understand which children with ADHD will respond well to stimulant medications. The goal is to help doctors choose the right treatment faster by looking at brain activity patterns before starting medication.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
Hear when a new Kbg Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.